Most cases of cervical cancer are caused by infection with the Human Papillomavirus (HPV), which is commonly transmitted through sexual or skin-to-skin contact. The HPV vaccine, also known as the cervical cancer vaccine, offers protection against the two primary strains of HPV virus—strains 16 and 18—that are responsible for 70% of cervical cancer cases. Getting vaccinated before potential exposure to these strains is considered the optimal timing for preventing cervical cancer.
The HPV vaccine is recommended for women between the ages of 9 and 26. It is administered in three doses. This vaccine has been shown to reduce the likelihood of cervical cancer by more than 90% (9-valent vaccine) or up to 70% (4-valent vaccine). Research suggests that its protection against HPV can last for at least 10 years.
For adults aged 27-45 who have not previously been vaccinated against cervical cancer, it is advisable to consult a doctor to determine whether the HPV vaccine is appropriate for you and to undergo cervical cancer screening.
Yes, it's still important to undergo cervical cancer screening because the objectives of HPV vaccination are distinct from those of cervical cancer screening. Women aged 21 to 65 should undergo screening for cervical cancer every three years. Specifically, women aged 30 and above should undergo screening using one of the following methods:
Program | Promotion Price (THB) |
4-valent HPV Vaccine (3 doses) | 7,800 |
9-valent HPV Vaccine (3 doses) | 19,000 |
Terms and Conditions